At Anji, we focus on high-value, innovative projects that have been credentialed by human data. With a lean asset-centric operational model that avoids bureaucracy and red tape, we can pursue the best ideas and work quickly and efficiently to help patients across the globe.
Our custom-built portfolio prioritizes unmet need, without limitations on disease area or therapeutic modality.
Anji Pharma and Population Health Partners Enter into Strategic Collaboration to Jointly Address High Prevalence Human Disease
Anji Pharma Completes Patient Enrollment in Phase 2 Study of Pradigastat in Functional Constipation